Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT)
To access this article, please choose from the options below
PII: S0002-8703(04)00393-X
doi:10.1016/j.ahj.2004.06.001
© 2004 Elsevier Inc. All rights reserved.
